Acamprosate Terminated Phase 3 Trials for Anxiety Disorders / Schizophrenic Disorders / Dementias / Depression / Psychosomatic Disorders Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT02374567Pharmacovigilance in Gerontopsychiatric Patients